Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Exocrine Pancreas Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Early research (Phase 1)Study completedNCT00985777
What this trial is testing

Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia

Who this might be right for
Pancreatic Neoplasms
H. Lee Moffitt Cancer Center and Research Institute 26
Not applicableLooking for participantsNCT07396662
What this trial is testing

Endocrine-exocrine Functions and Prognosis After Pancreatectomy

Who this might be right for
Pancreatic Neoplasm
National Taiwan University Hospital 3,500
Testing effectiveness (Phase 2)Study completedNCT04953962
What this trial is testing

Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Stage IV
CanBas Co. Ltd. 36
Not applicableNot Yet RecruitingNCT07670871
What this trial is testing

Exocrine-Endocrine Pancreatic Crosstalk: Precision Pathways to Reframe Diabetes Pathophysiology

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Chronic PancreatitisPrediabetes+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 440
Early research (Phase 1)Ended earlyNCT04665921
What this trial is testing

SGN-STNV in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small Cell LungHER2 Negative Breast NeoplasmsOvarian Neoplasms+9 more
Seagen Inc. 111
Not applicableWithdrawnNCT01412684
What this trial is testing

Distal Pancreatectomy With Partial Splenectomy for Pancreatic Tumors

Who this might be right for
Tumor of Exocrine Pancreas
University of Missouri-Columbia
Not applicableStudy completedNCT02818907
What this trial is testing

Evaluation of Survival Prognostic Factors for Patients With Exocrine Pancreatic Cancer Resectable or Potentially Resectable

Who this might be right for
Pancreatic Cancer
Centre Hospitalier Universitaire de Besancon 290
Not applicableStudy completedNCT04406571
What this trial is testing

Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
CHU de Reims 700
Testing effectiveness (Phase 2)Ended earlyNCT03822936
What this trial is testing

Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma

Who this might be right for
Cancer of PancreasPancreas AdenocarcinomaResectable Pancreatic Cancer
CNAO National Center of Oncological Hadrontherapy 30
Testing effectiveness (Phase 2)Looking for participantsNCT07341737
What this trial is testing

SL-28 for Advanced Solid Tumours

Who this might be right for
Head & Neck CancerPancreas CarcinomaPancreas Cancer, Metastatic+15 more
Second Life Therapeutics 60
Testing effectiveness (Phase 2)UnknownNCT01728818
What this trial is testing

Afatinib as Cancer Therapy for Exocrine Pancreatic Tumours

Who this might be right for
Focus of Study Instead
PD Dr. med. Volker Heinemann 119
Not applicableWithdrawnNCT01094600
What this trial is testing

Comparison of Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) to Endoscopic Pancreatic Function Test (ePFT) in Diagnosing Pancreatic Exocrine Insufficiency

Who this might be right for
Pancreatic Cancer
Columbia University
Testing effectiveness (Phase 2)UnknownNCT06393166
What this trial is testing

Sequential AG and mFOLFOX Combined With Serplulimab Injection and Bevacizumab Injection in Untreated Advanced Pancreatic Cancer

Who this might be right for
Non-Resectable Pancreas Carcinoma
Zhejiang Cancer Hospital 37
Early research (Phase 1)Study completedNCT00220649
What this trial is testing

Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Neoplasms
St. Luke's-Roosevelt Hospital Center 25
Early research (Phase 1)Study completedNCT00681798
What this trial is testing

Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma

Who this might be right for
Pancreatic Cancer
Sanofi 8
Not applicableStudy completedNCT03871790
What this trial is testing

Peptide-based Immunization for Colon- and and Pancreas-carcinoma

Who this might be right for
Colon NeoplasmColon AdenocarcinomaColon Cancer+9 more
CENTOGENE GmbH Rostock 50
Testing effectiveness (Phase 2)Looking for participantsNCT04084496
What this trial is testing

MFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
Sun Yat-sen University 80
Testing effectiveness (Phase 2)Ended earlyNCT04983407
What this trial is testing

Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
Aravive, Inc. 34
Testing effectiveness (Phase 2)UnknownNCT00690300
What this trial is testing

Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic Cancer

Who this might be right for
Pancreas Neoplasms
University of Ulm 44